The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
The role of short-chain fatty acids in microbiota–gut–brain communication
Open accessAbstract
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these SCFAs regulate the expression levels of tryptophan 5-hydroxylase 1, the enzyme involved in synthesis of serotonin, and tyrosine hydroxylase, which is involved in a rate-limiting step in the biosynthesis of dopamine, noradrenaline and adrenaline; therefore, producing an effect on brain neurochemistry (21, 55, 56, 116, 117).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbial metabolites such as short chain fatty acids (SCFAs) exert beneficial effects on psychiatric disorders via the microbiota–gut–brain axis through humoral, hormonal, and immune pathways [12].”
From Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SCFAs exert their physiological activities by acting as endogenous ligands for G-protein-coupled receptors (GPCRs), and modulating gene expression by inhibiting histone deacetylases (HDACs).282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
The cited source says what the claim attributes to it.
In the citing paper
“Other pathways through which SCFAs can influence gutbrain communication and brain function include immune, endocrine, neuronal, vagal, and other humoral pathways (360).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [360]
The cited source says what the claim attributes to it.
In the citing paper
“growing evidence supports the idea that SCFAs also exert crucial physiological effects on several organs, including the brain (17, 20, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Accumulating evidence suggests that SCFAs that cross into the CNS have neuroactive properties.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“It was described that SCFAs may modulate the levels of neurotransmitters and neurotrophic factors.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
In the citing paper
“SCFAs are endogenous ligands for a subset of GPCRs, including GPR43 and GPR41, which were subsequently renamed as free fatty acid receptor 2 (FFAR2) and FFAR3, respectively.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“Another important GPCR activated by SCFA is GPR109A, also known as hydroxycarboxylic acid receptor 2 (HCAR2), which is activated by butyrate and β-D-hydroxy butyrate.282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“and intracellular SCFAs can influence gene expression via histone deacetylation (HDAC) inhibition (Dalile et al., 2019)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Moreover, SCFAs are endogenous ligands of orphan G protein-coupled receptors (GPCRs)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Self-citationCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Cited by
Sorted by citations
Items 101–200 of 1,008
Gut bacterial nutrient preferences quantified in vivo
Zeng, X., Xing, X., Gupta, M., Keber, F. C., Lopez, J. G., Lee, Y.-C. J., Roichman, A., Wang, L., Neinast, M. D., Donia, M. S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.020 · Cited by 208
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Dalile, B., Vervliet, B., Bergonzelli, G., Verbeke, K., & Van Oudenhove, L. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0732-x · Cited by 201
Self-citationGut microbiota bridges dietary nutrients and host immunity
Fan, L., Xia, Y., Wang, Y., Han, D., Liu, Y., Li, J., Fu, J., Wang, L., Gan, Z., Liu, B., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2346-1 · Cited by 201
You’ve got male: Sex and the microbiota-gut-brain axis across the lifespan
Jaggar, M., Rea, K., Spichak, S., Dinan, T. G., & Cryan, J. F. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100815 · Cited by 200
Butyrate Shapes Immune Cell Fate and Function in Allergic Asthma
Yip, W., Hughes, M. R., Li, Y., Cait, A., Hirst, M., Mohn, W. W., & McNagny, K. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628453 · Cited by 197
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics
Tan, A. H., Chong, C. W., Lim, S., Yap, I. K. S., Teh, C. S. J., Loke, M. F., Song, S., Tan, J. Y., Ang, B. H., Tan, Y. Q., et al. (2021) · Annals of Neurology · doi:10.1002/ana.25982 · Cited by 196
Lei, Y., Tang, L., Liu, S., Hu, S., Wu, L., Liu, Y., Yang, M., Huang, S., Tang, X., Tang, T., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01065-2 · Cited by 196
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
Anand, N., Gorantla, V. R., & Chidambaram, S. B. (2022) · Cells · doi:10.3390/cells12010054 · Cited by 194
The microbiome-gut-brain axis in acute and chronic brain diseases
Benakis, C., Martin‐Gallausiaux, C., Trezzi, J., Melton, P., Liesz, A., & Wilmes, P. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.009 · Cited by 189
Wang, B., Zhang, L., Wang, Y., Dai, T., Qin, Z., Zhou, F., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00986-0 · Cited by 187
Short-chain fatty acid, acylation and cardiovascular diseases
Chen, X., Chen, X., & Tang, X. (2020) · Clinical Science · doi:10.1042/cs20200128 · Cited by 189
Zhang, K., Ma, Y., Luo, Y., Song, Y., Xiong, G., Ma, Y., Sun, X., & Kan, C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1253506 · Cited by 187
Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damage
Seki, D., Mayer, M., Hausmann, B., Pjevac, P., Giordano, V., Goeral, K., Unterasinger, L., Klebermaß-Schrehof, K., Paepe, K. D., de Wiele, T. V., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.004 · Cited by 186
Targeted Delivery of Probiotics: Perspectives on Research and Commercialization
Yoha, K. S., Nida, S., Dutta, S., Moses, J. A., & Anandharamakrishnan, C. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09791-7 · Cited by 185
Knez, E., Kadac-Czapska, K., & Grembecka, M. (2023) · Life · doi:10.3390/life13030655 · Cited by 181
Kalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103092 · Cited by 185
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 178
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
Trapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd1707 · Cited by 176
Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?
Miri, S., Yeo, J., Abubaker, S., & Hammami, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1098412 · Cited by 176
Plant Prebiotics and Their Role in the Amelioration of Diseases
Kaur, A. P., Bhardwaj, S., Dhanjal, D. S., Nepovimová, E., Martins, N. A., Kuča, K., Chopra, C., Singh, R., Kumar, H., Şen, F., et al. (2021) · Biomolecules · doi:10.3390/biom11030440 · Cited by 174
Pu, Y., Tan, Y., Qu, Y., Chang, L., Wang, S., Wei, Y., Wang, X., & Hashimoto, K. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.032 · Cited by 172
Snigdha, S., Ha, K., Tsai, P., Dinan, T. G., Bartos, J. D., & Shahid, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107978 · Cited by 173
Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 169
Dual role of microbiota-derived short-chain fatty acids on host and pathogen
Mirzaei, R., Dehkhodaie, E., Bouzari, B., Rahimi, M., Gholestani, A., Hosseini‐Fard, S. R., Keyvani, H., Teimoori, A., & Karampoor, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112352 · Cited by 167
The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Chidambaram, S. B., Rathipriya, A. G., Mahalakshmi, A. M., Sonali, S., Hediyal, T. A., Ray, B., Sunanda, T., Rungratanawanich, W., Kashyap, R. S., Qoronfleh, M. W., et al. (2022) · Cells · doi:10.3390/cells11071239 · Cited by 168
Effects of dietary fibre on metabolic health and obesity
Deehan, E. C., Mocanu, V., & Madsen, K. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00891-z · Cited by 172
Impact of Environmental Pollutants on Gut Microbiome and Mental Health via the Gut–Brain Axis
Singh, S., Sharma, P., Pal, N., Kumawat, M., Shubham, S., Sarma, D. K., Tiwari, R. R., Kumar, M., & Nagpal, R. (2022) · Microorganisms · doi:10.3390/microorganisms10071457 · Cited by 161
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 160
Ma, N., He, T., Johnston, L. J., & Ma, X. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1758008 · Cited by 162
Chen, L., Liu, B., Ren, L., Du, H., Fei, C., Qian, C., Li, B., Zhang, R., Liu, H., Li, Z., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1069954 · Cited by 155
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 156
Donoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 155
Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling
Torres‐Fuentes, C., Golubeva, A. V., Zhdanov, A. V., Wallace, S., Arboleya, S., Papkovsky, D. B., Aidy, S. E., Ross, P., Roy, B. L., Stanton, C., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901433r · Cited by 154
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153
Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior
Medawar, E., Haange, S., Rolle-Kampczyk, U. E., Engelmann, B., Dietrich, A., Thieleking, R., Wiegank, C., Fries, C., Horstmann, A., Villringer, A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01620-3 · Cited by 153
Sun, Y., Zhang, H., Zhang, X., Wang, W., Chen, Y., Cai, Z., Wang, Q., Wang, J., & Shi, Y. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102690 · Cited by 151
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Wang, Z., Li, Y., Liao, W., Huang, J., Liu, Y., Li, Z., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935723 · Cited by 154
Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links
Lee, H.-S., Lobbestael, E., Vermeire, S., Sabino, J., & Cleynen, I. (2021) · Gut · doi:10.1136/gutjnl-2020-322429 · Cited by 151
Microbiota‐gut‐brain axis as a regulator of reward processes
García‐Cabrerizo, R., Carbia, C., O’Riordan, K. J., Schellekens, H., & Cryan, J. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15284 · Cited by 150
Eicher, T. P., & Mohajeri, M. H. (2022) · Nutrients · doi:10.3390/nu14132661 · Cited by 151
Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)
Sun, J., Chen, S., Zang, D., Sun, H., Sun, Y., & Chen, J. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5632 · Cited by 157
Chang, H. M., Foo, H. L., Loh, T. C., Lim, E. T. C., & Mutalib, N. E. A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.602280 · Cited by 149
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 150
Microbiota–neuroepithelial signalling across the gut–brain axis
Ohara, T. E., & Hsiao, E. Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01136-9 · Cited by 147
Tang, S., Liu, W., Zhao, Q., Li, K., Zhu, J., Yao, W., & Gao, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113280 · Cited by 147
Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors
Gwak, M.-G., & Chang, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e20 · Cited by 151
Tian, T., Mao, Q., Xie, J., Wang, Y., Shao, W., Zhong, Q., & Chen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.10.002 · Cited by 151
Araújo-Rodrigues, H., Sousa, A. S., Relvas, J. B., Tavaria, F. K., & Pintado, M. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.121978 · Cited by 147
Das, U. N. (2021) · Biomolecules · doi:10.3390/biom11020241 · Cited by 145
Lai, Z., Shan, W., Li, J., Jia, M., Zeng, X., & Zuo, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01291-y · Cited by 147
Cheng, X. M., Tan, Y., Li, H., Huang, J., Zhao, D., Zhang, Z., Yi, M., Zhu, L., Hui, S., Yang, J., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106312 · Cited by 145
Ecklu-Mensah, G., Choo-Kang, C., Maseng, M. G., Donato, S., Bovet, P., Viswanathan, B., Bedu-Addo, K., Plange‐Rhule, J., Boateng, P. O., Forrester, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40874-x · Cited by 147
Ren, M., Zhang, H., Qi, J., Hu, A., Jiang, Q., Hou, Y., Feng, Q., Ojo, O., & Wang, X. (2020) · Nutrients · doi:10.3390/nu12103036 · Cited by 147
The microbiota-gut-bone axis and bone health
Tu, Y., Yang, R., Xu, X., & Zhou, X. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0321-755r · Cited by 144
Nabavi-Rad, A., Sadeghi, A., Aghdaei, H. A., Yadegar, A., Smith, S. M., & Zali, M. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2108655 · Cited by 144
Barrio, C., Arias-Sánchez, S., & Martín-Monzón, I. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105640 · Cited by 143
SH-SY5Y Cell Line In Vitro Models for Parkinson Disease Research—Old Practice for New Trends
Ioghen, O. C., Ceafalan, L. C., & Popescu, B. O. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201020 · Cited by 142
Short chain fatty acids: the messengers from down below
Mansuy‐Aubert, V., & Ravussin, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1197759 · Cited by 144
Xu, M., Mo, X., Huang, H., Chen, X., Liu, H., Peng, Z., Chen, L., Rong, S., Yang, W. Q., Xu, S., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.180 · Cited by 140
Mycotoxin and Gut Microbiota Interactions
Guerre, P. (2020) · Toxins · doi:10.3390/toxins12120769 · Cited by 139
Aaldijk, E., & Vermeiren, Y. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101556 · Cited by 138
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00730-8 · Cited by 137
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Sun, Y., Wang, X., Li, L., Zhong, C., Zhang, Y., Yang, X., Li, M., & Yang, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1328324 · Cited by 141
Gut microbiome in Parkinson's disease: New insights from meta-analysis
Toh, T. S., Chong, C. W., Lim, S., Bowman, J. S., Cirstea, M. S., Lin, C., Chen, C., Appel‐Cresswell, S., Finlay, B. B., & Tan, A. H. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.11.017 · Cited by 138
Singh, A., D'Amico, D. F., Andreux, P. A., DunnGalvin, G., Kern, T., Blanco-Bose, W. E., Auwerx, J. H., Aebischer, P., & Rinsch, C. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00950-1 · Cited by 135
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021) · JGH Open · doi:10.1002/jgh3.12528 · Cited by 134
Wang, H., Yang, F., Zhang, S., Xin, R., & Sun, Y. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00213-7 · Cited by 135
Tan, Q., Orsso, C. E., Deehan, E. C., Kung, J. Y. C., Tun, H. M., Wine, E., Madsen, K. L., Zwaigenbaum, L., & Haqq, A. M. (2021) · Autism Research · doi:10.1002/aur.2560 · Cited by 133
The gut microbiome and mental health: advances in research and emerging priorities
Shoubridge, A. P., Choo, J. M., Martin, A. M., Keating, D. J., Wong, M., Licinio, J., & Rogers, G. B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01479-w · Cited by 133
Jiao, W., Lin, J., Deng, Y., Ji, Y., Liang, C., Wei, S., Xi, J., & Yan, F. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03312-3 · Cited by 132
Cao, Q., Shen, M., Li, R., Liu, Y., Zeng, Z., Zhou, J., Niu, D., Zhang, Q., Wang, R., Yao, J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03454-y · Cited by 138
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data
Kircher, B., Woltemate, S., Gutzki, F. M., Schlüter, D., Geffers, R., Bähre, H., & Vital, M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2149019 · Cited by 133
Turroni, S., Magnani, M., Pukar, K. C., Lesnik, P., Vidal, H., & Heer, M. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.553929 · Cited by 132
Liu, Z., Li, L., Ma, S., Jin, Y., Zhang, H., Li, Y., Sair, A. T., Pan, J., Liu, X., Li, X., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04290 · Cited by 129
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 129
Wu, S., Bekhit, A. E. A., Wu, Q., Chen, M., Liao, X., Wang, J., & Ding, Y. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.019 · Cited by 129
Khan, A., Ding, Z., Ishaq, M. H., Bacha, A. S., KHAN, I. A., Hanif, A., Li, W., & Guo, X. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56214 · Cited by 130
Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study
Fan, J., Zhou, Y., Meng, R., Tang, J., Zhu, J., Aldrich, M. C., Cox, N. J., Zhu, Y., Li, Y., & Zhou, D. (2023) · BMC Medicine · doi:10.1186/s12916-023-02863-1 · Cited by 128
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Verma, A., Bhagchandani, T., Rai, A., Nikita, N., Sardarni, U. K., Bhavesh, N. S., Gulati, S., Malik, R., & Tandon, R. (2024) · ACS Omega · doi:10.1021/acsomega.3c05846 · Cited by 127
Chen, C., Wang, G., Li, D., & Zhang, F. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00307-1 · Cited by 133
Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology
Xie, J., Bruggeman, A., De Nolf, C., Vandendriessche, C., Van Imschoot, G., Van Wonterghem, E., Vereecke, L., & Vandenbroucke, R. E. (2023) · The EMBO Journal · doi:10.15252/embj.2022111515 · Cited by 125
The impact of maternal high-fat diet on offspring neurodevelopment
Urbonaite, G., Knyzeliene, A., Bunn, F. S., Smalskys, A., & Neniškytė, U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909762 · Cited by 124
Zhu, F., Tu, H., & Chen, T. (2022) · Nutrients · doi:10.3390/nu14102081 · Cited by 123
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
Xie, A., Ensink, E., Li, P., Gordevičius, J., Marshall, L. L., George, S., Pospisilik, J. A., Aho, V. T. E., Houser, M. C., Pereira, P. A. B., et al. (2022) · Movement Disorders · doi:10.1002/mds.29128 · Cited by 123
Short chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 123
Short-chain fatty acids (SCFAs) in gut health: Implications for drug metabolism and therapeutics
Sankarganesh, P., Bhunia, A., Kumar, A. G., Babu, A. S., Gopukumar, S. T., & Elumalai, L. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100139 · Cited by 123
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Abdalqadir, N., & Adeli, K. (2022) · Microorganisms · doi:10.3390/microorganisms10102061 · Cited by 119
Gut microbiota–derived short-chain fatty acids protect against the progression of endometriosis
Chadchan, S. B., Popli, P., Ambati, C. R., Tycksen, E., Han, S. J., Bulun, S. E., Putluri, N., Biest, S. W., & Kommagani, R. (2021) · Life Science Alliance · doi:10.26508/lsa.202101224 · Cited by 119
Hegelmaier, T., Lebbing, M., Duscha, A., Tomaske, L., Tönges, L., Holm, J. B., Bjørn Nielsen, H., Gatermann, S. G., Przuntek, H., & Haghikia, A. (2020) · Cells · doi:10.3390/cells9020376 · Cited by 118
Bloemendaal, M., Szopinska-Tokov, J., Belzer, C., Boverhoff, D., Papalini, S., Michels, F., van Hemert, S., Arias Vasquez, A., & Aarts, E. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01404-9 · Cited by 118
Wang, S., Ishima, T., Qu, Y., Shan, J., Chang, L., Wei, Y., Zhang, J., Pu, Y., Fujita, Y., Tan, Y., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.006 · Cited by 118
The Implication of Short-Chain Fatty Acids in Obesity and Diabetes
Anachad, O., Taouil, A., Taha, W., Bennis, F., & Chegdani, F. (2023) · Microbiology Insights · doi:10.1177/11786361231162720 · Cited by 121
Boundaries and integration between microbiota, the nervous system, and immunity
Macpherson, A. J., Pachnis, V., & Prinz, M. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.011 · Cited by 118
Coker, J. K. C., Moyne, O., Rodionov, D. A., & Zengler, K. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869502 · Cited by 117
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases
Peppas, S., Pansieri, C., Piovani, D., Danese, S., Peyrin‐Biroulet, L., Tsantes, A. G., Brunetta, E., Tsantes, A. Ε., & Bonovas, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030377 · Cited by 116
Metadata
- Authors
- Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Verbeke, Kristin
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-05-23
- Volume
- 16
- Issue
- 8
- Pages
- 461-478
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2946372752
- Cited by
- 3,357
- References
- 289
- Citations by year
- 2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
